The present invention relates to a method for preparing a protein cage which comprises: a 1.sup.st step of preparing an amphiphilic polymer comprising a 1.sup.st hydrophobic polymer and a 1.sup.st hydrophilic functional group; a 2.sup.nd step of preparing a hydrophilic protein comprising a 2.sup.nd functional group binding to the 1.sup.st functional group; a 3.sup.rd step of forming an amphiphilic polymer-protein hybrid by the binding of the 1.sup.st functional group and the 2.sup.nd functional group, and forming core-shell structured particles comprising a protein shell and an amphiphilic polymer core by the self-assembly of the amphiphilic polymer in a hydrophilic solvent; and a fourth step of removing some or all of the hydrophobic polymer of the core part from the core-shell structured particles.

The present invention relates to a small molecule inhibitor for use in the prevention of maturation of dental plaque biofilms. A further application may be the reduction of the risk for diseases associated with functions that derive from matured dental plaque biofilms. The invention also relates to the use of an effective amount of a small molecule inhibitor in a cosmetic product for the prevention of maturation of dental biofilms. The present invention also relates to oral compositions comprising an effective amount of a small molecule inhibitor suitable for the prevention of maturation of dental plaque biofilms. The present invention further relates to a device for application of oral compositions further comprising an oral composition comprising an effective amount of a small molecule inhibitor suitable for the prevention of maturation of dental plaque biofilms.

A process, for example a continuous process, for making an oral care article of manufacture containing a fibrous composition, for example a composite structure, and more particularly to a process for making an oral care article of manufacture containing a fibrous composition, such as a soluble fibrous composition, containing soluble filaments is provided.

Oral care compositions and methods for the same are provided herein. The oral care composition may include an orally acceptable vehicle, a peroxide whitening agent, and one or more gelling agents. The gelling agents may include a fatty acid. The gelling agents may be free or substantially free of fatty alcohols. The gelling agents may include at least one of palmitic acid, stearic acid, or mixtures thereof.

The claimed invention is lotion candle/melt. There is no wax in the product. They are safe if consumed by pets or children. They ae also safe for the environment being as they are not made from a kerosine by product. They are also safe to apply on your skin as a moisturizer due to the fact that they do not contain any wax product that is produced from kerosene. Child and pet safe they can be consumed with out harmful side effects being that they're made of all natural material if you are not allergic They contain no petroleum byproducts.

An oral care composition with an aqueous phase, hydrophobic phase, active agent, and optionally emulsifier. A jammed emulsion with aqueous phase, hydrophobic phase, active agent, and optionally emulsifier. An oral care composition with aqueous phase, hydrophobic phase, active agent, and optionally emulsifier. Methods of using disclosed compositions for active agent delivery.

A single-use oral delivery device includes a housing unit configured to house a predetermined amount of oral medication, vitamins and or minerals to be applied to an interdental space of a user, and an interdental device configured to be interlocked with the housing unit, wherein the interdental device includes a cap at a top portion for interlocking and sealing with the housing unit, and an applicator tip at a bottom portion for applying oral medication, vitamins or minerals to the interdental space.

The disclosure provides compounds that inhibit the invasion of host cells by intracellular parasites. These find use, for example, in treating and preventing periodontitis or a periodontitis-related condition or symptom.

Process for making up an area of human keratin materials using a makeup device having a transfer surface and a coat of at least one cosmetic colouring ink borne by the transfer surface and obtained by printing using at least one digital printer, the colouring ink being intended to be applied to the keratin materials. The process includes the following steps: forming a base coating by applying at least one cosmetic composition comprising an oil onto the area of the keratin materials to be made up, and producing a pattern on the area of the keratin materials by placing the coat of cosmetic ink in contact with the base coating present on the area to be made up so as to transfer the coat of cosmetic ink onto the keratin materials.

An oral care composition comprising zinc phosphate and stannous fluoride.